Nephrogenic systemic fibrosis versus contrast-induced nephropathy: Risks and benefits of contrast-enhanced MR and CT in renally impaired patients

Diego R. Martin, Richard C. Semelka, Arlene Chapman, Harm Peters, Paul Finn, Bobby Kalb, Henrik Thomsen

    Research output: Contribution to journalArticlepeer-review

    35 Citations (Scopus)

    Abstract

    Magnetic resonance imaging (MRI) and computed tomography (CT) have become essential to diagnostic evaluation of many, or most, important medically and surgically treated diseases. It is important to consider comprehensively the implications in making decisions when choosing one or the other cross-sectional imaging modality. Factors to consider include the relative risks of the contrast agent. Other factors include the relative procedural risks, including radiation risks and the relative expected diagnostic yield of the examination technique (1,2). In this review we describe both nephrogenic systemic fibrosis and contrast-induced nephropathy to compare the implications with regard to relative risks and benefits of contrast-enhanced MRI or CT in patients with impaired renal function.

    Original languageEnglish
    Pages (from-to)1350-1356
    Number of pages7
    JournalJournal of Magnetic Resonance Imaging
    Volume30
    Issue number6
    DOIs
    Publication statusPublished - 1 Dec 2009

    Fingerprint Dive into the research topics of 'Nephrogenic systemic fibrosis versus contrast-induced nephropathy: Risks and benefits of contrast-enhanced MR and CT in renally impaired patients'. Together they form a unique fingerprint.

    Cite this